ZEE+ Painaid ESF Tablets Recalled for Failed Stability Specifications
Ultra Seal Corporation is recalling ZEE+ Painaid ESF Extra-Strength Formula tablets nationwide due to out-of-specification results for Salicylic Acid, an aspirin-related compound. The recall affects 50-count and 125-count packages with lot numbers AK-9547 (exp. April 22) and AK-9941 (exp. December 22).
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall involving failed stability specifications with no reported illnesses or injuries. The hazard is theoretical and relates to quality control rather than an immediate safety threat. Class III recalls are typically scored as 1 or 2 per the rubric.
Plain-English summary
Ultra Seal Corporation is recalling ZEE+ Painaid ESF Extra-Strength Formula tablets nationwide. The tablets contain Acetaminophen 250 mg, Aspirin 250 mg (NSAID), and Caffeine 65 mg, and are sold in 2-tablet packages within 50-count and 125-count cartons (lot number PA-ESF 1414Z).
The recall has been initiated due to failed stability specifications. Out-of-specification results were observed for Salicylic Acid, an aspirin-related compound. A total of 1,968,150 tablets are affected by this recall.
Affected lot numbers are AK-9547 (expiration date April 22) and AK-9941 (expiration date December 22). These products were distributed nationwide in the USA and are distributed by Zee Medical Distributors, LLC in Mason, Ohio.
Consumers who have purchased these products should discontinue use and consult their healthcare provider with questions about their health or the use of this product.
The recalled product
- Product
- ZEE+ painaid ESF Extra-Strength Formula (Acetaminophen 250 mg, Aspirin 250 mg (NSAID), Caffeine 65 mg) tablets, 2 Tablets per/package, Packaged in a) 50-count packages/carton, b) 125-count packages/carton, PA-ESF 1414Z, Dist. by: Zee Medical Distributors, LLC Mason, OH 45040 (Shi
- Manufacturer
- Ultra Seal Corporation
- Hazard
- stability-failure
- out-of-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: AK-9547
- exp. date 22- Apr
- AK-9941
- exp. date 22-Dec
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27